Abstract:Kai Wu, 1, * Qiong Feng, 2, * Liang Li, 1 Yanfei Xiong, 3 Shihong Liu, 4 Jie Liu, 1 Qing Wu 1 1 Department of Orthopedics, The Second Affiliated Hospital of Nanchang University, Nanchang 300006, People's Republic of China; 2 Nursing School, Nanchang University, Nanchang 300006, People's Republic of China; 3 Department of Orthopedics, Jingan Hospital, Yichun 330600, People's Republic of China; 4 Jingan Hospital of Traditional Chinese Medicine, Yichun 330600, People's Republic of China *These authors contributed equally to this work Correspondence: Qing Wu Email wuqing18186@126.com Introduction: The long-noncoding RNA PCAT6 plays an important regulatory role in the development of several cancers. However, the expression pattern and underlying mechanisms of PCAT6 in osteosarcoma (OS) are yet unknown. Methods: We used real-time PCR to measure PCAT6 expression in 106 tumor pairs and corresponding non-tumor tissues from OS patients. Statistical analyses were applied to evaluate the prognostic value and associations of PCAT6 expression with clinical parameters. Furthermore, the PCAT6 was silenced with siRNA in OS cells. Moreover, phenotype of PCAT6 silenced OS cells was measured using colony formation, CCK-8, cell migration and invasion assay. Finally, the molecular mechanism of PCAT6/miR-143-3p/ZEB1 axis in OS progression was explored. Results: The expression level of PCAT6 in OS tissues was significantly elevated as compared with that in the adjacent normal bone tissues and that high PCAT6 expression closely correlated with the malignant phenotype and poor survival among patients with OS. Multivariate analyses revealed PCAT6 overexpression as an independent prognostic factor for the poor outcome of patients with OS. Functional assay results demonstrated that the knockdown of PCAT6 expression notably suppressed the proliferation, migration, and invasion of OS cells. An elevated PCAT6 level aggravated the malignant phenotype of OS cells via ZEB1 expression upregulation. Mechanistic studies revealed that PCAT6 could sponge endogenous miR-143-3p and inhibit its activity, resulting in an increase in ZEB1 level. Finally, we demonstrated that the tumour-promoting role of PCAT6 in OS was dependent on the regulation of the miR-143-3p/ZEB1 axis. Conclusion: These findings highlight the potential role of PCAT6, which could serve as a valuable prognostic indicator for patients with OS. Keywords: osteosarcoma, PCAT6, ZEB1, miR-143-3p

MATN4 as a target gene of HIF-1α promotes the proliferation and metastasis of osteosarcoma

Zinc finger Asp-His-His-Cys palmitoyl -acyltransferase 19 accelerates tumor progression through wnt/β-catenin pathway and is upregulated by miR-940 in osteosarcoma

The TAZ–miR-224–SMAD4 Axis Promotes Tumorigenesis in Osteosarcoma

LncRNA SATB2-AS1 Promotes Tumor Growth and Metastasis and Affects the Tumor Immune Microenvironment in Osteosarcoma by Regulating SATB2

MAT1 Facilitates the Lung Metastasis of Osteosarcoma Through Upregulation of AKT1 Expression.

Nectin-4 promotes osteosarcoma progression and metastasis through activating PI3K/AKT/NF-κB signaling by down-regulation of miR-520c-3p

ACTN4 Promotes the Proliferation, Migration, Metastasis of Osteosarcoma and Enhances Its Invasive Ability Through the NF-κB Pathway

MicroRNA-455-3p Inhibits Osteosarcoma Progression Via HSF1 Downregulation

MALAT1 Promotes Osteosarcoma Development by Regulation of HMGB1 Via Mir-142-3p and Mir-129-5p

HIF-1α-mediated augmentation of miRNA-18b-5p facilitates proliferation and metastasis in osteosarcoma through attenuation PHF2

Hypoxia inducible factor-1ɑ as a potential therapeutic target for osteosarcoma metastasis

Long Noncoding RNA MALAT1 Interacts with miR-124-3p to Modulate Osteosarcoma Progression by Targeting SphK1

MYLK4 promotes tumor progression through the activation of epidermal growth factor receptor signaling in osteosarcoma

Long non-coding RNA Taurine upregulated gene 1 promotes osteosarcoma cell metastasis by mediating HIF-1α via miR-143-5p

ACSL4 accelerates osteosarcoma progression via modulating TGF-β/Smad2 signaling pathway

MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway

NDUFA4L2 Regulated by HIF-1α Promotes Metastasis and Epithelial–Mesenchymal Transition of Osteosarcoma Cells Through Inhibiting ROS Production

Hypoxia-driven TNS4 fosters HNSCC tumorigenesis by stabilizing integrin α5β1 complex and triggering FAK-mediated Akt and TGFβ signaling pathways

HSPD1 Supports Osteosarcoma Progression through Stabilizing ATP5A1 and thus Activation of AKT/mTOR Signaling

LncRNA MALAT1 Promotes Cancer Metastasis in Osteosarcoma Via Activation of the PI3K-Akt Signaling Pathway.

Long-Noncoding RNA PCAT6 Aggravates Osteosarcoma Tumourigenesis via the MiR-143-3p/ZEB1 Axis